These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 9927492)
21. Interleukin-6 induces G1 arrest through induction of p27(Kip1), a cyclin-dependent kinase inhibitor, and neuron-like morphology in LNCaP prostate tumor cells. Mori S; Murakami-Mori K; Bonavida B Biochem Biophys Res Commun; 1999 Apr; 257(2):609-14. PubMed ID: 10198259 [TBL] [Abstract][Full Text] [Related]
22. sst2 somatostatin receptor mediates cell cycle arrest and induction of p27(Kip1). Evidence for the role of SHP-1. Pagès P; Benali N; Saint-Laurent N; Estève JP; Schally AV; Tkaczuk J; Vaysse N; Susini C; Buscail L J Biol Chem; 1999 May; 274(21):15186-93. PubMed ID: 10329727 [TBL] [Abstract][Full Text] [Related]
23. Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-beta and a contrasting decrease in p27(Kip1). Farley J; Gray K; Nycum L; Prentice M; Birrer MJ; Jakowlew SB Gynecol Oncol; 2000 Aug; 78(2):113-22. PubMed ID: 10926789 [TBL] [Abstract][Full Text] [Related]
24. Expression of p27kip1 in prostatic adenocarcinoma. Cheville JC; Lloyd RV; Sebo TJ; Cheng L; Erickson L; Bostwick DG; Lohse CM; Wollan P Mod Pathol; 1998 Apr; 11(4):324-8. PubMed ID: 9578081 [TBL] [Abstract][Full Text] [Related]
25. Modulation of intrinsic P-glycoprotein expression in multicellular prostate tumor spheroids by cell cycle inhibitors. Wartenberg M; Fischer K; Hescheler J; Sauer H Biochim Biophys Acta; 2002 Feb; 1589(1):49-62. PubMed ID: 11909640 [TBL] [Abstract][Full Text] [Related]
26. The expression of p18INK4 and p27kip1 cyclin-dependent kinase inhibitors is regulated differently during human B cell differentiation. Schrantz N; Beney GE; Auffredou MT; Bourgeade MF; Leca G; Vazquez A J Immunol; 2000 Oct; 165(8):4346-52. PubMed ID: 11035070 [TBL] [Abstract][Full Text] [Related]
27. Requirement for p27(KIP1) in retinoblastoma protein-mediated senescence. Alexander K; Hinds PW Mol Cell Biol; 2001 Jun; 21(11):3616-31. PubMed ID: 11340156 [TBL] [Abstract][Full Text] [Related]
28. Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival. Del Pizzo JJ; Borkowski A; Jacobs SC; Kyprianou N Am J Pathol; 1999 Oct; 155(4):1129-36. PubMed ID: 10514396 [TBL] [Abstract][Full Text] [Related]
29. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1). Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520 [TBL] [Abstract][Full Text] [Related]
30. E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1). St Croix B; Sheehan C; Rak JW; Flørenes VA; Slingerland JM; Kerbel RS J Cell Biol; 1998 Jul; 142(2):557-71. PubMed ID: 9679152 [TBL] [Abstract][Full Text] [Related]
31. Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer. Vis AN; Noordzij MA; Fitoz K; Wildhagen MF; Schröder FH; van der Kwast TH J Urol; 2000 Dec; 164(6):2156-61. PubMed ID: 11061947 [TBL] [Abstract][Full Text] [Related]
32. Accumulation of a form of p27(Kip1) not associated with Cdk-cyclin complexes in transforming growth factor-beta-arrested Mv1Lu cells. Taipale M; Tiihonen E; Heiskanen A; Laiho M Exp Cell Res; 2000 Aug; 259(1):107-16. PubMed ID: 10942583 [TBL] [Abstract][Full Text] [Related]
33. Multiple functions of p27(Kip1) and its alterations in tumor cells: a review. Sgambato A; Cittadini A; Faraglia B; Weinstein IB J Cell Physiol; 2000 Apr; 183(1):18-27. PubMed ID: 10699962 [TBL] [Abstract][Full Text] [Related]
34. Protein kinase Cdelta inhibition of S-phase transition in capillary endothelial cells involves the cyclin-dependent kinase inhibitor p27(Kip1). Ashton AW; Watanabe G; Albanese C; Harrington EO; Ware JA; Pestell RG J Biol Chem; 1999 Jul; 274(30):20805-11. PubMed ID: 10409620 [TBL] [Abstract][Full Text] [Related]
36. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation. Tanner FC; Boehm M; Akyürek LM; San H; Yang ZY; Tashiro J; Nabel GJ; Nabel EG Circulation; 2000 May; 101(17):2022-5. PubMed ID: 10790340 [TBL] [Abstract][Full Text] [Related]
37. Reduced expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in human colon cancer. Sgambato A; Ratto C; Faraglia B; Merico M; Ardito R; Schinzari G; Romano G; Cittadini AR Mol Carcinog; 1999 Nov; 26(3):172-9. PubMed ID: 10559792 [TBL] [Abstract][Full Text] [Related]
38. Mimosine arrests cells in G1 by enhancing the levels of p27(Kip1). Wang G; Miskimins R; Miskimins WK Exp Cell Res; 2000 Jan; 254(1):64-71. PubMed ID: 10623466 [TBL] [Abstract][Full Text] [Related]
39. Reduced expression of the CDK inhibitor p27(KIP1) in rat two-stage bladder carcinogenesis and its association with expression profiles of p21(WAF1/Cip1) and p53. Lee CC; Ichihara T; Yamamoto S; Wanibuchi H; Sugimura K; Wada S; Kishimoto T; Fukushima S Carcinogenesis; 1999 Sep; 20(9):1697-708. PubMed ID: 10469613 [TBL] [Abstract][Full Text] [Related]
40. Cyclin-dependent kinase inhibitor P27(KIP1) is expressed preferentially in early stages of urothelial carcinoma. Franke KH; Miklosi M; Goebell P; Clasen S; Steinhoff C; Anastasiadis AG; Gerharz C; Schulz WA Urology; 2000 Oct; 56(4):689-95. PubMed ID: 11018640 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]